Abbott is buying Cardiovascular Systems for $890 million, or $20 per share. Transaction is subject to CSI shareholder approval and customary closing conditions, including applicable regulatory approvals.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept